![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cytomyx Hldgs | LSE:CYX | London | Ordinary Share | GB0033942276 | ORD 2.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.10 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:3349R Cytomyx Holdings PLC 15 September 2005 For immediate release 15 September 2005 CYTOMYX HOLDINGS PLC ("Cytomyx" or the "Company") Directorate Change Cytomyx Holdings plc (AIM: CYX), a leading provider of drug discovery products and services, announces that Alan Seeley has resigned as a Director of the Company with immediate effect to pursue other business interests. For further information, please contact: Cytomyx Holdings plc +44 (0) 1223 508191 Mike Kerins, Chief Executive Buchanan Communications +44 (0) 20 7466 5000 Mark Court/Mary-Jane Johnson This information is provided by RNS The company news service from the London Stock Exchange END BOAEELFFEKBEBBZ
1 Year Cytomyx Chart |
1 Month Cytomyx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions